BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11221512)

  • 21. Rare presentations of primary melanoma and special populations: a systematic review.
    Kottschade LA; Grotz TE; Dronca RS; Salomao DR; Pulido JS; Wasif N; Jakub JW; Bagaria SP; Kumar R; Kaur JS; Morita SY; Moran SL; Nguyen JT; Nguyen EC; Hand JL; Erickson LA; Brewer JD; Baum CL; Miller RC; Swanson DL; Lowe V; Markovic SN
    Am J Clin Oncol; 2014 Dec; 37(6):635-41. PubMed ID: 23563206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral mucosal melanoma: a series of case reports.
    Garzino-Demo P; Fasolis M; Maggiore GM; Pagano M; Berrone S
    J Craniomaxillofac Surg; 2004 Aug; 32(4):251-7. PubMed ID: 15262258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary melanoma of the central nervous system].
    Zhang Y; Chen L; Wu J; Qin Z; Zhang F
    Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):283-4. PubMed ID: 12828166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ocular metastases of solid extraocular tumors. Frequency of ocular metastases and localization of the primary tumors].
    Królewska K; Palacz O; Zajaczek S
    Klin Oczna; 2004; 106(1-2):102-6. PubMed ID: 15218777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
    Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
    Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
    Zettersten E; Sagebiel RW; Miller JR; Tallapureddy S; Leong SP; Kashani-Sabet M
    Cancer; 2002 Feb; 94(4):1049-56. PubMed ID: 11920475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histologic-prognostic and clinical considerations on 6 cases of melanoblastoma of the head].
    Milazzo F
    Arch Ital Otol Rinol Laringol; 1966; 77(2):174-84. PubMed ID: 4380189
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary extracutaneous malignant melanoma: a comprehensive review with emphasis on treatment.
    Thoelke A; Willrodt S; Hauschild A; Schadendorf D
    Onkologie; 2004 Oct; 27(5):492-9. PubMed ID: 15585982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study.
    Kim HS; Kim EK; Jun HJ; Oh SY; Park KW; Lim DH; Lee SI; Kim JH; Kim KM; Lee DH; Lee J
    BMC Cancer; 2010 Apr; 10():167. PubMed ID: 20426858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment.
    Rager EL; Bridgeford EP; Ollila DW
    Am Fam Physician; 2005 Jul; 72(2):269-76. PubMed ID: 16050450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anatomic site, sun exposure, and risk of cutaneous melanoma.
    Whiteman DC; Stickley M; Watt P; Hughes MC; Davis MB; Green AC
    J Clin Oncol; 2006 Jul; 24(19):3172-7. PubMed ID: 16809740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor size and depth in primary malignant melanoma in the oral cavity influences survival.
    Mücke T; Hölzle F; Kesting MR; Loeffelbein DJ; Robitzky LK; Hohlweg-Majert B; Tannapfel A; Wolff KD
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1409-15. PubMed ID: 19531410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical manifestations and treatment of melanoma of the central nervous system: analysis of 15 cases].
    Li Y; Wang S; Zhao JZ
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(2):134-7. PubMed ID: 14990130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanomas in renal transplant recipients.
    Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
    Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
    Einwachter-Thompson J; MacKie RM
    Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers in melanoma: staging, prognosis and detection of early metastases.
    Carlson JA; Slominski A; Linette GP; Mihm MC; Ross JS
    Expert Rev Mol Diagn; 2003 May; 3(3):303-30. PubMed ID: 12779006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival outcomes of mucosal melanoma in the USA.
    Al-Haseni A; Vrable A; Qureshi MM; Mathews S; Pollock S; Truong MT; Sahni D
    Future Oncol; 2019 Dec; 15(34):3977-3986. PubMed ID: 31724885
    [No Abstract]   [Full Text] [Related]  

  • 40. Tissue culture of human tumors: its use and prospects.
    Ioachim HL
    Pathol Annu; 1970; 5():217-56. PubMed ID: 4329826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.